Immunovant, Inc. (IMVT)
NASDAQ: IMVT · IEX Real-Time Price · USD
26.52
-0.99 (-3.60%)
At close: Jul 2, 2024, 4:00 PM
26.02
-0.50 (-1.89%)
After-hours: Jul 2, 2024, 7:56 PM EDT
Immunovant Market Cap
Immunovant has a market cap or net worth of $3.88 billion as of July 2, 2024. Its market cap has increased by 54.43% in one year.
Market Cap
3.88B
Enterprise Value
3.24B
1-Year Change
54.43%
Ranking
Category
Stock Price
$26.52
Market Cap Chart
Since May 10, 2019, Immunovant's market cap has increased from $128.30M to $3.88B, an increase of 2,921.59%. That is a compound annual growth rate of 93.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 3.87B | -36.45% |
| Dec 29, 2023 | 6.09B | 165.79% |
| Dec 30, 2022 | 2.29B | 134.03% |
| Dec 31, 2021 | 979.80M | -78.33% |
| Dec 31, 2020 | 4.52B | 1,882.29% |
| Dec 31, 2019 | 228.10M | 77.79% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 4.08B |
| Inspire Medical Systems | 3.98B |
| Merus | 3.92B |
| Avidity Biosciences | 3.91B |
| Integer Holdings | 3.88B |
| Axsome Therapeutics | 3.82B |
| Ultragenyx Pharmaceutical | 3.72B |
| Waystar Holding | 3.58B |